Live Analyst Rating Changes 23586 upgrades, downgrades & price-target moves · freshest Wall Street data, updated daily View live feed →
Analyst Tracker/Neal Gilmer
HAYW

Neal Gilmer

Wall Street Analyst
★★☆☆☆
#2232
on 13Foresight · ranked by our own returns
62%
Success Rate
+135.8%
Average Return
8 of 13 calls profitable · +123.6% vs benchmark
S&P 500 (SPY)
📈 Across the calls we could measure, roughly 62% of Neal Gilmer's ratings turned a profit when each position was held for 1 year — averaging +135.8% per rating. These figures are computed by 13Foresight from historical prices, not supplied by the analyst.

Rating Distribution

47 Buy 0 Hold 0 Sell
Neal's Stock Coverage 19 ratings · 2026-08-12
Company Date Position Consensus Price Target 1-Yr Return vs S&P 500
TRLV
Trulieve Cannabis
Aug 07, 2026 BUY Strong Buy
+141.1% avg upside
15 analysts
$17.25
89.22% Upside
+0.0% ·
TSE:CL
Cresco Labs
Aug 06, 2026 BUY Strong Buy
+416.8% avg upside
13 analysts
$2.30
121.21% Upside
· ·
TSE:VRNO
Verano Holdings
Aug 05, 2026 BUY Strong Buy
+156.1% avg upside
8 analysts
$18.75
139.84% Upside
· ·
TSE:GTII
Green Thumb Industries
Aug 05, 2026 BUY Strong Buy
+112.9% avg upside
15 analysts
$20.50
104.92% Upside
· ·
TSE:HITI
High Tide
Aug 04, 2026 BUY Strong Buy
+115.9% avg upside
9 analysts
$8.00
143.97% Upside
· ·
TSE:LOVE
Cannara Biotech
Jul 14, 2026 BUY Strong Buy
+68.4% avg upside
3 analysts
$3.00
51.60% Upside
+1.1% ·
TSE:DB
Decibel Cannabis Company
May 21, 2026 BUY Strong Buy
+127.3% avg upside
4 analysts
$0.25
127.22% Upside
· ·
TSE:AAWH.USD
Ascend Wellness Holdings LLC
May 20, 2026 BUY Strong Buy
6 analysts
$1.00
· ·
TSE:XLY
Auxly Cannabis Group
May 19, 2026 BUY Buy
-95.2% avg upside
3 analysts
$0.25
92.14% Downside
+1865.5% ·
TSE:OGI
Organigram Global
May 18, 2026 BUY Buy
+164.9% avg upside
11 analysts
$3.25
91.19% Upside
-5.5% ·
TSE:ROMJ
Rubicon Organics
May 14, 2026 BUY Strong Buy
+133.3% avg upside
3 analysts
$1.30
162.54% Upside
· ·
TSE:CURA
Curaleaf Holdings
Nov 06, 2025 BUY Strong Buy
+5.7% avg upside
13 analysts
$15.00
8.42% Upside
+25.5% ·
TLRY
Tilray
Apr 09, 2025 HOLD Hold
+78.4% avg upside
24 analysts
$6.00
30.19% Upside
+26.8% ·
TSE:EAGR
Leaf Mobile Inc
May 09, 2024 BUY Strong Buy
+5978.5% avg upside
4 analysts
$1.50
1664.70% Upside
-54.9% ·
FFNTF
4Front Ventures
Jan 09, 2024 SELL Hold
+79161300.0% avg upside
2 analysts
$0.15
14999900.02% Upside
· ·
TSE:VEXT
Vext Science
Mar 22, 2023 BUY Strong Buy
+429.0% avg upside
3 analysts
$0.98
268.51% Upside
+14.6% ·
TSE:BRAG
Bragg Gaming Group Inc
Sep 19, 2022 BUY Strong Buy
+378.1% avg upside
10 analysts
$15.00
527.68% Upside
+10.8% ·
TSE:ILLM
illumin Holdings
Jan 12, 2021 BUY Strong Buy
+470.2% avg upside
9 analysts
$19.00
2335.81% Upside
· ·
TSE:DHB
Delivra Health Brands
Mar 04, 2020 SELL Hold
+249.9% avg upside
2 analysts
$0.10
11.08% Upside
-93.3% ·
🔒 14 more ratings — with price targets, crowd consensus and our measured returns.
Free account unlocks every analyst's full coverage table.
Neal Gilmer — Frequently Asked Questions
How accurate are Neal Gilmer's stock ratings?
Based on the calls 13Foresight could measure, about 62% of Neal's ratings were profitable over a one-year hold, with an average return of +135.8% per rating, or +123.6% versus the S&P 500. We score every analyst the same way, from historical prices. Each return is measured in the stock's own trading currency, so for non-US listings the S&P 500 comparison leaves out currency moves.
How is Neal ranked on 13Foresight?
Neal Gilmer is currently ranked #2232 with a 2-star rating. Our rank blends hit rate, average return versus the market, and how many calls we have to judge — so a long, consistent record outweighs a few lucky picks. It is our own calculation, updated daily.
Which stocks does Neal cover?
Neal most recently has ratings on TRLV, TSE:CL, TSE:VRNO, TSE:GTII, TSE:HITI, TSE:LOVE, TSE:DB, TSE:AAWH.USD, TSE:XLY, TSE:OGI, TSE:ROMJ, TSE:CURA and 7 more. See the full coverage table above for positions, price targets and our measured returns.
Where can I see other analyst ratings?
Browse the full analyst leaderboard to compare Wall Street analysts ranked by their measured performance, success rate and average return.

Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.